Majd Ahmad PharmD MBA BCPS BCOP
Mebane,NC
Summary
Seasoned medical affairs professional with a strong background in fostering communication and building relationships. Skilled in team collaboration and adept at navigating changing needs to achieve results. Expertise in conflict resolution, project management, and strategic planning. Reliable, adaptable, and focused on driving success through effective partnerships and clear communication.
Overview
11
11
years of professional experience
1
1
Certification
Work History
Principal Medical Science Liaison – Gynecologic Oncology
Daiichi Sankyo
Basking Ridge, NJ
09.2025 - Current
- Part of the field medical team buildout for Daiichi Sankyo’s Gynecologic Oncology program
- Establish and maintain scientifically credible relationships with national and regional KEEs in addition to other healthcare providers
- Assist in training FMA in the ovarian cancer landscape and certifying MSL team
- Serve as asset lead for Trastuzumab Deruxtecan and represent field medical in MPT as well as CMT meetings with AstraZeneca
- Serve as trial lead for Destiny-Ovarian01 and Destiny Endometrial02
- Assist in the planning and execution of clinically relevant regional medical meetings and congresses
- Part of the US Believe Recruitment and Retention workforce
- Assisted with the Vision and Culture taskforce for Project UNITI
Principal Medical Science Liaison – Early Dev, Rare Tumors & Hematology
Daiichi Sankyo
Basking Ridge, NJ
11.2024 - 12.2025
- Establish and maintain scientifically credible relationships with national and regional KEEs and TLs
- Collaborate with cross-functional teams to create effective territory plans that engage HCPs and improve patient outcomes
- Provide valuable feedback and insights to internal stakeholders regarding emerging clinical and scientific trends
- Assist in the planning and execution of clinically relevant regional medical meetings and congresses
- Identify and verify potential investigators and sites for company-sponsored clinical trials
- Act as a liaison for the submission and review of Investigator-Sponsored Research proposals
- Support major and regional congresses by engaging with thought leaders
Field Medical Director (MSL) – Hematology/Oncology
Beigene
San Mateo, CA
07.2023 - 04.2024
- Work with cross-functional teams to develop robust territory plans that impact and inform HCPs leading to improved patient outcomes
- Establish and maintain scientifically credible peer-to-peer scientific relationships with national & regional KOLs/TLs in addition to other healthcare providers
- Serve as an internal resource of clinical and scientific information from medical interactions
- Provide impactful feedback/information to internal stakeholders on emerging clinical and scientific trends
- Assist in the development and execution of clinically relevant regional medical meetings (e.g., advisory boards, consultants, and investigator meetings), as requested
- Identification and verification of investigators and sites for company-sponsored clinical trials
- Serve as a liaison for the submission and review of Investigator-Sponsored Research proposals
- Support major and regional congresses engaging thought leaders
- Work cross-functionally to provide balanced and accurate information to top regional formulary decision-makers and/or P&T committee members
Principal Medical Science Liaison – Precision Medicine Oncology
Bayer Healthcare
Whippany, NJ
06.2021 - 07.2023
- Involved in various task forces and initiatives such as Breast Cancer Initiative (Lead), MSL council (co-chair), sales trainer (Lead), CO-OP (Lead), Grow Talent Taskforce (Lead), auditor for Bayer Sponsored CME and mentorship to one MSL and one fellow.
- Identify key thought leaders and establish, foster, cultivate, and maintain relationships with healthcare providers in academic and community centers within the Mid-Atlantic/Southeast territory
- Provide insights/feedback on emerging scientific/clinical data on Bayer Oncology products and Pipeline
- Present appropriate clinical and scientific information to healthcare providers in response to unsolicited requests in a fair and balanced manner
Clinical Pharmacy Specialist- Hematology/Oncology/Bone Marrow Transplant
UNC Healthcare
Chapel Hill, NC
03.2018 - 06.2021
- Participated in daily multidisciplinary rounds and provided recommendations to optimize drug therapy
- Researched, collected, and communicated the latest medical literature concerning treatment options and the highest standards of care
- Worked with clinical trial coordinators, doctors, and nurses to ensure treatment protocol compliance and adherence to agreed timelines
- Counseled patients on efficacy and safety when initiating a new treatment regimen to increase adherence
- Served as a strong advocate for patients by striving to increase disease awareness and resource programs
- Precepted pharmacy students from UNC Eshelman School of Pharmacy, as well as post-graduate pharmacists
Lead Oncology Pharmacist
New York Presbyterian/Columbia University Irving Medical Center
New York, NY
07.2015 - 03.2018
- Served as the Lead Pharmacist for the Oncology Pharmacy Group
- Designed, implemented, and modified monitoring plans to assess patient-specific outcomes to the therapeutic plan, including outcomes related to concomitant disease states (e.g., symptom evaluation, adverse-effect evaluation, physical and laboratory assessment, frequency and duration of follow-up)
- Collaborated with management, both pharmacy, and nursing, to improve workflow to ensure patients in an outpatient setting get their medication in a timely fashion
- Performed educational in-services for staff on new drug therapy or current drug therapy with new indication
Education
Master’s in Business Administration (MBA) -
Louisiana State University- Shreveport
Shreveport, LA01-2023
Doctor of Pharmacy -
St. John’s University College of Pharmacy & Health Sciences
Jamaica, NY01-2015
SCIENTIFIC PRESENTATION EXPERIENCE
- Comparative Effectiveness of Larotrectinib and Entrectinib in NTRK Gene Fusion Cancer Audience: Precision Medicine Medical Affairs Team Mar 2022
- Treatment and Testing Updates in Lung Cancer Audience: Precision Medicine Account Leads and Diagnostic Managers Feb 2022
- Precision Medicine in Breast Cancer Audience: Precision Medicine Medical Affairs Team Jan 2022
- Treatment Options in ALK+ Non-small Cell Lung Cancer Audience: PGY2 Pharmacy Residents UNC Health: Chapel Hill, NC Aug 2020
- Oncological Emergencies Pharmacy Residency Boot Camp UNC Health: Chapel Hill, NC July 2020
- Updates in Relapsed/Refractory Follicular Lymphoma Audience: Clinical Oncology Pharmacists UNC Health: Chapel Hill, NC Dec 2019
- Oncological Emergencies Pharmacy Residency Boot Camp UNC Health: Chapel Hill, NC July 2019
- Fundamentals of Bone Marrow Transplant Audience: Pharmacy Students from UNC Eshelman School of Pharmacy UNC Health: Chapel Hill, NC Sept 2018
- Updates in Acute Myeloid Leukemia Audience: Clinical Oncology Pharmacists UNC Health: Chapel Hill, NC March 2018
- Copanlisib: Novel PI3K Inhibitor for Relapsed Refractory Follicular Lymphoma Audience: Chemotherapy Pharmacists New York Presbyterian Hospital-Herbert Irving Pavilion Dec 2017
- Daratumumab Updated FDA Indication Audience: Chemotherapy Pharmacists New York Presbyterian Hospital-Herbert Irving Pavilion June 2017
- Hazardous Medications Used for Non-Oncology Indications Nursing Education Series New York Presbyterian Hospital-Herbert Irving Pavilion Sept 2016
Research Experience
- Stocker K., Ahmad M., Deal A., Agegnehu B., Borlagden J., Auten, JJ, Muluneh B., Zeidner JF. Real-world Safety and Efficacy Analysis of Venetoclax with Concomitant Triazole Antifungals for Patients with Acute Myeloid Leukemia. Hematology/Oncology Pharmacy Association Annual Conference. Tampa, Florida (March 2020)
- Bucci T., Deal A., Ahmad M., Szeto A.H., Zhu A., Cass A., Crona D.J., Muluneh, B. Response to Tyrosine Kinase Inhibitors in Real-world Patients with Chronic Myeloid Leukemia Hematology/Oncology Pharmacy Association Annual Conference. Fort Worth, Texas (March 2019)
PUBLICATIONS
- Szeto AH, Bucci T, Deal A, Ahmad M, Zhu A Cass AS, Sketch MR, Zeidner JF, Foster Muluneh B, Crona DJ Response to Tyrosine Kinase Inhibitors in Real World Patients with Chronic Myeloid Leukemia Status: Published
- Stocker K, Ahmad M, Auten JJ Muluneh B, Agegnehu B, Borlagdan J, Deal A, Zeidner JF Real-World Safety and Efficacy Analysis of Venetoclax with Concomitant Triazole Antifungals for Patients with Acute Myeloid Leukemia Status: Manuscript in Progress
HONORS AND AWARDS
Q3 Bayer Oncology Director Award October 2022
H1 Top Performer Award, Bayer Healthcare August 2022
Q1 Bayer Oncology Director Award, Bayer Healthcare April 2022
Experiential Preceptor of the Year, UNC Healthcare April 2021
Affiliations
- American Society of Clinical Oncology 2021- Present
- Hematology Oncology Pharmacy Association 2017-Present
- Phi Lambda Sigma, Pharmacy Leadership Society Inducted 2014
- The Rho Chi Society, Academic Honor Society in Pharmacy Inducted 2013
- American Society of Health-System Pharmacists 2013-Present
- American Pharmacists Association 2010-2015
Certification
- Certificate of Completion: Extreme Ownership Leadership Course Jan 2024
- Certificate of Achievement in Precision Oncology, Harvard Medical School Jan 2023
- Certificate of Achievement in Genetics, Harvard Medical School June 2022
- Teaching and Learning Certificate May 2021
- NIH: Principles and Practice of Clinical Research Oct 2020
- Board Certified Oncology Pharmacy Specialist (#5151803) Oct 2020
- NIH: Principles of Clinical Pharmacology Sep 2020
- Board Certified Pharmacotherapy Specialist (#3162053) June 2020
- CERTaIN: Pragmatic Clinical Trials and Healthcare Delivery Evaluations Feb 2020
- Pharmacist License (#26724), North Carolina Board of Pharmacy 2017-Present
- Advanced Cardiovascular Life Support, American Heart Association 2016-Present
- Basic Life Support, American Heart Association 2015-Present
- Pharmacist License (#060553), New York Board of Pharmacy 2015-Present
Timeline
Principal Medical Science Liaison – Gynecologic Oncology
Daiichi Sankyo
09.2025 - Current
Principal Medical Science Liaison – Early Dev, Rare Tumors & Hematology
Daiichi Sankyo
11.2024 - 12.2025
Field Medical Director (MSL) – Hematology/Oncology
Beigene
07.2023 - 04.2024
Principal Medical Science Liaison – Precision Medicine Oncology
Bayer Healthcare
06.2021 - 07.2023
Clinical Pharmacy Specialist- Hematology/Oncology/Bone Marrow Transplant
UNC Healthcare
03.2018 - 06.2021
Lead Oncology Pharmacist
New York Presbyterian/Columbia University Irving Medical Center
07.2015 - 03.2018
Master’s in Business Administration (MBA) -
Louisiana State University- Shreveport
Doctor of Pharmacy -
St. John’s University College of Pharmacy & Health Sciences